title: Mass conversion from Sandimmun to Sandimmun Neoral: 1 1/2-year experience.
authors.affiliation: King Fahad National Guard Hospital, Riyadh, Saudi Arabia.
authors.forename: S
authors.initials: S
authors.lastname: Huraib
authors.forename: W
authors.initials: W
authors.lastname: al Khudair
authors.forename: H
authors.initials: H
authors.lastname: Selim
authors.forename: A
authors.initials: A
authors.lastname: Iqbal
authors.forename: K
authors.initials: K
authors.lastname: Quadri
authors.forename: S
authors.initials: S
authors.lastname: Abu Romeh
authors.forename: A
authors.initials: A
authors.lastname: Chaballout
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D004304:Dosage Forms; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D012529:Saudi Arabia
chemical_list: D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine